Related Articles
Synthesis and positron emission tomography evaluation of 18F-Glu-Urea-Lys, a prostate-specific membrane antigen-based imaging agent for prostate cancer Corrigendum in /10.3892/ol.2015.4039
Targeting foreign major histocompatibility complex molecules to tumors by tumor cell specific single chain antibody (scFv)
In vivo targeted killing of prostate tumor cells by a synthetic amoebapore helix 3 peptide modified with two γ-linked glutamate residues at the COOH terminus
Expression, purification and identification of an immunogenic fragment in the ectodomain of prostate‑specific membrane antigen
Development of a 124I-labeled version of the anti-PSMA monoclonal antibody capromab for immunoPET staging of prostate cancer: Aspects of labeling chemistry and biodistribution